Sage Therapeutics News

Sage Therapeutics | 8-K: Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Apr 25 06:50 ET

Sage Therapeutics | DEFA14A: Others

Apr 24 16:16 ET

Sage Therapeutics | DEF 14A: Definitive information statements

Apr 24 16:10 ET

Sage Therapeutics | 8-K: Current report

Apr 19 08:33 ET

Sage Therapeutics | 8-K: Current report

Apr 17 06:38 ET

Sage Therapeutics | 8-K: Current report

Mar 26 08:39 ET

Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 14 07:51 ET

Sage Therapeutics | 8-K: Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress

Feb 14 06:46 ET

Sage Therapeutics | 8-K: Current report

Jan 31 16:53 ET

Sage Therapeutics | 8-K: Current report

Jan 24 16:15 ET

Sage Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Sage Therapeutics | DEFA14A: Others

Dec 19, 2023 08:32 ET

Sage Therapeutics | DEF 14A: Definitive information statements

Dec 19, 2023 08:30 ET

Sage Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 8, 2023 08:30 ET

Sage Therapeutics | 8-K: Current report

Nov 7, 2023 07:39 ET

Sage Therapeutics | 8-K: Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

Nov 7, 2023 06:46 ET

Sage Therapeutics | 8-K: Current report

Aug 31, 2023 06:45 ET

Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 7, 2023 07:49 ET

Sage Therapeutics | 8-K: Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

Aug 7, 2023 06:45 ET

Sage Therapeutics | 8-K: Current report

Jun 16, 2023 16:06 ET